Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Aug 23, 2019
Targets & Mechanisms
New targets in osteoarthritis are about more than just pain
With mechanistic insights and a nudge from FDA, companies are taking OA past analgesics into disease-modifying targets
BioCentury | Feb 4, 2013
Emerging Company Profile
Incanthera: Using, not targeting, MMP
Incanthera using matrix metalloproteinase to activate prodrugs against cancer
BioCentury | Jun 18, 2012
Emerging Company Profile
Armour: Relaxin in CRPC
Armour targets relaxin in prostate cancer; may complement anti-androgen drugs
Items per page:
1 - 10 of 98